Heparinases obtained from sphingobacterium daejeonense, preparation therefor and application thereof
AssigneeShenzhen Hepalink Pharmaceutical Group Co., Ltd.
InventorJiake Bai
Life of this patent
Estimating the term…
Abstract
Heparinases SDhep I and SDhep II obtained from a bacterium Sphingobacterium daejeonense are heparin enzymes that have not been reported. The enzymes were obtained by steps of bacterium fermentation, crude enzyme extraction, multi-step column chromatography and so on. A study in properties showed that the two enzymes are specific for enzymolysis of heparin and are expected to be used in low molecular weight heparins preparation or heparin quality testing.
Claims10
A heparinases SDhep I and SDhep II obtained from Sphingobacterium daejeonense.
A method for obtaining heparinases SDhep I and SDhep II from Sphingobacterium daejeonense bacterium, comprising the following steps:
- (1) the Sphingobacterium daejeonense is inoculated on the slant medium;
- (2) the strain obtained in step (1) is inoculated into the seed culture medium and cultured for 1-2 days, inoculated into a secondary liquid seed medium and cultured for 1-2 days, and then inoculated into 2 L fermentation medium and cultured for 1-5 days, thereafter cells are collected;
- (3) the cells obtained in step (2) are suspended in Tris-HCl buffer, disrupted by a high pressure homogenizer, then centrifuged for a supernatant and subjected to ammonium sulfate precipitation in an ice bath to collect a precipitated component with 35%-85% saturation, and then the precipitate was dissolved in Tris-HCl buffer and dialyzed to obtain an enzyme solution;
- (4) the enzyme solution obtained in step (3) is loaded onto a Q column pre-equilibrated with a Tris-HCl buffer, then equilibrated with the same buffer and eluted with a linear gradient of a 0-0.5 M NaCl in the same buffer;
- wherein the fraction with enzyme activity collected from the effluent and equilibrate solution is heparinase SDhep I, which is not bound to the Q column;
- and wherein the fraction with heparinase activity collected from the eluate is heparinase SDhep II, which is bound to the Q column, then the fraction with heparinase activity collected from the eluate is combined and dialyzed;
- (5) the SDhep I fraction obtained in step (4) is loaded onto the CS column pre-equilibrated with a Tris-HCl buffer, then equilibrated with the same buffer and then eluted with a linear gradient of 0-0.5 M NaCl in the same buffer;
- the fractions with heparinase activity are collected, dialyzed and loaded onto the SP column pre-equilibrated with Tris-HCl buffer, then equilibrated with the same buffer and then equilibrated with Tris-HCl buffer with a linear gradient of 0-0.5 M NaCl;
- the fractions are collected and concentrated to 0.2 mL by an ultrafiltration centrifuge tube intercepting molecular weight of 30 kD;
- the concentrated enzyme is loaded onto a Sephadex G-100 column pre-equilibrated with a Tris-HCl buffer and then eluted with the same buffer;
- the fractions with activity are collected, combined and concentrated to obtain purified SDhep I;
- (6) SDhep II obtained in step (4) is loaded on a CS column pre-equilibrated with Tris-HCl buffer, then equilibrated with the same buffer, and then eluted with a linear gradient 0.1-0.6 M NaCl in the same buffer;
- the fractions with heparinase activity in eluent solution are tested, collected, combined and dialyzed;
- the enzyme solution is loaded onto a Q-column pre-equilibrated with Tris-HCl buffer, and eluted with a linear gradient of 0.08 M NaCl in the same buffer;
- the fractions are tested, collected and loaded onto a CS column pre-equilibrated with a Tris-HCl buffer, then equilibrated with the same buffer and then eluted with a linear gradient of 0-1 M NaCl in the same buffer;
- the fractions with activity are collected, combined, and concentrated to obtain purified SDhep II.
Dependencies are inferred from the claim text.